politicsNewsغير مصنف

Clinton targets Valeant price hikes in campaign appearance

(Reuters) – Shares of Valeant Pharmaceuticals International Inc fell on Thursday after the campaign of Democratic presidential contender Hillary Clinton posted a blog from an Iowa event detailing exorbitant price hikes for a migraine drug made by the company.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى